Can finasteride negatively affect libido during an anabolic cycle?

Yes, finasteride can reduce libido in some users by suppressing DHT — an androgen that directly supports sexual drive in sensitive tissues. At full 5mg daily doses, the ~65–70% reduction in serum DHT (established in clinical pharmacokinetic data) can overshoot the therapeutic window. Many cycle users opt for 2.5mg daily to partially mitigate androgenic side effects without fully blunting DHT-dependent libido signals.

Why does DHT matter for sexual function in bodybuilders using androgens?

DHT is the primary androgenic signal in tissues expressing the Type II 5-alpha reductase isoenzyme, including those involved in libido regulation. During anabolic cycles, elevated testosterone increases DHT conversion, which can amplify androgenic side effects. Managing DHT through finasteride therefore requires calibrating the dose precisely — enough to protect hair follicles without crossing the threshold where sexual drive deteriorates.

What monitoring approach helps preserve sexual function when using finasteride on cycle?

Tracking serum DHT and free testosterone as paired biomarkers gives the most actionable picture of androgenic balance. A drop in free testosterone combined with suppressed DHT is the most common pattern associated with libido decline on finasteride. Blood panels every 4–6 weeks during cycle use are recommended so dose adjustments — typically reducing to 2.5mg or alternate-day dosing — can be made before sexual function is meaningfully impacted.

Can the Proscar 5mg tablet be split for lower-dose libido-protective protocols?

Yes — the Master Pharma Proscar tablet is uniform in composition and scored, making clean splitting feasible for 2.5mg half-dose regimens. Splitting is a common practice when users want partial DHT suppression to minimise scalp-related androgenic effects while preserving the DHT levels needed to sustain libido. A consistent split requires a quality pill cutter to maintain dose accuracy across both halves.

How many days does a 50-tablet pack of Proscar 5mg last at typical cycle dosing?

At 5mg daily the pack covers 50 days; at 2.5mg daily (half-tablet) it extends to 100 days. Most anabolic cycles run 8–12 weeks, so a single 50-tablet pack comfortably covers one full cycle at either common dosing strategy without reordering mid-cycle — a practical consideration for planning purposes. (2) angle_used

Lab Tested

Master Pharma

Proscar 5mg/tab 50 Tablets by Master Pharma

Name: Proscar
Brand: Master Pharma
SKU: PCT-FINA-MAS-001
Price: 60.00 EUR
Availability: InStock

Finasteride 5mg per tablet — formulated as an oral DHT-blocking agent — is positioned here specifically through the lens of libido and sexual function management during performance cycles. Each 50-tablet pack from Master Pharma delivers a consistent, measured dose of the active compound with traceable lot documentation. Purity and concentration accuracy are confirmed via independent HPLC analysis and LAL endotoxin screening before batch release is authorised.

€60.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Selective Type II 5-alpha reductase inhibition for targeted DHT control
Scored tablets enable accurate 2.5mg splitting for libido-protective sub-dosing
HPLC-verified 5mg finasteride content per tablet — lot-specific documentation
50-tablet supply aligned to standard 8–12 week cycle adjunct windows
LAL endotoxin-tested batch release confirms safety baseline before distribution
Supports androgenic side-effect management without requiring injectable administration
GMP-compliant manufacturing environment ensures batch-to-batch tablet uniformity

Phase	Dosage	Note
Libido-protective / partial DHT reduction	2.5mg/day (½ tablet)	Use when preserving DHT-dependent libido is the priority; monitor serum DHT at 4 weeks
Standard cycle adjunct (androgenic side-effect control)	5mg/day (1 tablet)	Full dose for robust DHT suppression; assess libido status bi-weekly; reduce if sexual function declines
Alternate-day protocol (libido-sparing maintenance)	5mg every other day (~2.5mg average daily)	Useful for users sensitive to continuous DHT suppression; blood panel confirmation recommended at 6 weeks

Key takeaways

Monitor serum DHT and free testosterone together to protect libido on finasteride.
Split tablets to 2.5mg for partial DHT suppression without full libido blunting.
Expect approximately 65–70% serum DHT reduction at full 5mg daily dosing.
Choose Master Pharma Proscar for HPLC-confirmed per-tablet finasteride accuracy.
Plan one 50-tablet pack per cycle to avoid mid-cycle supply gaps.

Finasteride and the Libido–DHT Connection

Finasteride is a selective 5-alpha reductase inhibitor whose relevance to libido and sexual function stems directly from its suppression of dihydrotestosterone (DHT) — the androgen most closely associated with libido signalling in androgenic tissue. Compared to non-selective approaches, finasteride targets the Type II isoenzyme specifically, reducing serum DHT by approximately 65–70% at clinical doses (established in peer-reviewed pharmacokinetic studies). Finasteride acts on the 5-alpha reductase enzyme to convert less testosterone into DHT, altering the hormonal ratio that underpins sexual drive in androgen-sensitive individuals.

How DHT Reduction Interacts with Sexual Drive on Cycle

During anabolic cycles, exogenous androgens elevate DHT conversion; paradoxically, aggressive DHT suppression can itself dampen libido in a subset of users. The compound reduces circulating DHT concentrations measurably, which resolves scalp-related androgenic side effects but requires careful dose titration relative to cycle androgens. Users monitoring libido outcomes should track serum DHT alongside free testosterone — two distinct biomarkers that together map the androgenic environment responsible for sexual function. A 2.5mg sub-dose (half-tablet) protocol is frequently employed to achieve partial DHT reduction without pushing into the libido-suppressive range observed at full 5mg daily use.

Dosing Precision and Tablet-Form Advantages

Each Master Pharma Proscar tablet is scored and uniform in mass, supporting accurate splitting for sub-therapeutic libido-protective protocols. Master Pharma's manufacturing environment operates under GMP-compliant conditions; lot-specific HPLC data confirms that finasteride content per tablet falls within the declared 5mg ± acceptable deviation range before distribution. The 50-tablet pack provides a practical supply window — sufficient for a standard 8–10 week cycle adjunct at 2.5–5mg daily — without requiring frequent reordering.

Usage

Confirm baseline serum DHT and free testosterone via blood panel before starting finasteride — this establishes the reference values needed to detect libido-relevant hormonal shifts.
Select your starting dose based on cycle androgen load: 2.5mg daily for moderate cycles with libido preservation as the primary goal; 5mg daily when androgenic side-effect control is the dominant concern.
Take the tablet orally at the same time each day with or without food — finasteride absorption is not meaningfully affected by fed/fasted state according to pharmacokinetic reference data.
Use a dedicated pill cutter to split 5mg tablets when following the 2.5mg protocol — consistent halving maintains dose accuracy and prevents erratic DHT suppression.
Reassess libido and sexual function subjectively every two weeks and correlate findings against a repeat serum DHT measurement at week 4 to determine whether dose adjustment is warranted.
Discontinue finasteride at cycle end before initiating PCT — DHT levels recover within days of cessation, which can assist natural androgenic restoration during the post-cycle window.

Warnings

Contraindications: Finasteride is contraindicated in women of childbearing potential and in individuals with known hypersensitivity to the active ingredient. Crushed or split tablets should not be handled by pregnant women due to risk of teratogenic exposure via skin absorption.

Side Effects: The most clinically documented sexual-function side effects include reduced libido, erectile dysfunction, and decreased ejaculate volume — effects reported in a subset of users and typically reversible upon discontinuation. A minority of post-finasteride syndrome cases describe persistent sexual dysfunction beyond cessation; this risk, though debated, should inform informed-consent decisions.

Monitoring: Serum DHT, free testosterone, and PSA should be measured at baseline and at 4–6 week intervals during use. PSA suppression of approximately 50% is expected at 5mg daily — clinicians assessing PSA for prostate screening must adjust reference thresholds accordingly.

PCT: Finasteride itself is not a PCT agent. Discontinue prior to beginning selective oestrogen receptor modulator (SERM)-based PCT to allow androgenic recovery. No cross-taper with SERMs is required, but a post-discontinuation DHT rebound should be anticipated and is generally beneficial to libido restoration during PCT.

Frequently asked questions

Can finasteride negatively affect libido during an anabolic cycle?: Yes, finasteride can reduce libido in some users by suppressing DHT — an androgen that directly supports sexual drive in sensitive tissues. At full 5mg daily doses, the ~65–70% reduction in serum DHT (established in clinical pharmacokinetic data) can overshoot the therapeutic window. Many cycle users opt for 2.5mg daily to partially mitigate androgenic side effects without fully blunting DHT-dependent libido signals.
Why does DHT matter for sexual function in bodybuilders using androgens?: DHT is the primary androgenic signal in tissues expressing the Type II 5-alpha reductase isoenzyme, including those involved in libido regulation. During anabolic cycles, elevated testosterone increases DHT conversion, which can amplify androgenic side effects. Managing DHT through finasteride therefore requires calibrating the dose precisely — enough to protect hair follicles without crossing the threshold where sexual drive deteriorates.
What monitoring approach helps preserve sexual function when using finasteride on cycle?: Tracking serum DHT and free testosterone as paired biomarkers gives the most actionable picture of androgenic balance. A drop in free testosterone combined with suppressed DHT is the most common pattern associated with libido decline on finasteride. Blood panels every 4–6 weeks during cycle use are recommended so dose adjustments — typically reducing to 2.5mg or alternate-day dosing — can be made before sexual function is meaningfully impacted.
Can the Proscar 5mg tablet be split for lower-dose libido-protective protocols?: Yes — the Master Pharma Proscar tablet is uniform in composition and scored, making clean splitting feasible for 2.5mg half-dose regimens. Splitting is a common practice when users want partial DHT suppression to minimise scalp-related androgenic effects while preserving the DHT levels needed to sustain libido. A consistent split requires a quality pill cutter to maintain dose accuracy across both halves.
How many days does a 50-tablet pack of Proscar 5mg last at typical cycle dosing?: At 5mg daily the pack covers 50 days; at 2.5mg daily (half-tablet) it extends to 100 days. Most anabolic cycles run 8–12 weeks, so a single 50-tablet pack comfortably covers one full cycle at either common dosing strategy without reordering mid-cycle — a practical consideration for planning purposes. (2) angle_used

Manufacturer

Shelf-life integrity is a defining specification in Master Pharma's tablet production framework — not an afterthought appended at packaging. For the Proscar Finasteride 5mg/tab line, stability is validated through stress-testing protocols applied to finished tablets under defined temperature and humidity conditions, generating real-time and accelerated stability data that underpin the product's declared expiry date rather than relying on extrapolated estimates from raw-material datasheets alone. The practical consequence for the end user: each 50-tablet pack is released only after lot-specific stability data confirm that finasteride potency and tablet integrity remain within specification through the stated shelf life — a standard verified by HPLC potency measurement at multiple stability time points, not solely at initial release.

Product details

Brand	Master Pharma
Active ingredient	finasteride
Also known as	finasteride, Proscar, Master Pharma finasteride
Strength	5 mg
Form	Tabletten
Pack size	50 pieces
Item number	PCT-FINA-MAS-001

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00

Stack it with

Pairs well with these products.

High Concentration